We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+1.05%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.4B
AUM Growth
+$612M
Cap. Flow
+$41M
Cap. Flow %
0.76%
Top 10 Hldgs %
51.53%
Holding
1,375
New
399
Increased
402
Reduced
270
Closed
267
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
5.5 quarters
Top 20 Avg Time Held Equity + Options
5.2 quarters
Avg Time Held Equity only
1.3 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.6 quarters

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$20.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.8M
3
BIDU icon
Baidu
BIDU
+$6.27M
4
CMCSA icon
Comcast
CMCSA
+$5.98M
5
MSFT icon
Microsoft
MSFT
+$5.98M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$16.2M
2
YHOO
Yahoo Inc
YHOO
+$8.75M
3
BAC icon
Bank of America
BAC
+$8.19M
4
CVX icon
Chevron
CVX
+$6.68M
5
LNKD
LinkedIn Corporation
LNKD
+$6.14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.2%
2 Communication Services 1.81%
3 Energy 1.34%
4 Technology 0.97%
5 Consumer Discretionary 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MACK icon
1076
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$77K ﹤0.01%
+2,390
New +$102K
2016 Q4
0 quarters
DNR
1077
PUT
DELISTED
Denbury Resources, Inc.
DNR
$75K ﹤0.01%
+20,500
New +$65.9K
2016 Q4
0 quarters
SSI
1078
DELISTED
Stage Stores Inc
SSI
$74K ﹤0.01%
+17,015
New +$84.2K
2016 Q4
0 quarters
BCRX icon
1079
CALL
BioCryst Pharmaceuticals
BCRX
$2.06B
$73K ﹤0.01%
+11,500
New +$59.8K
2016 Q4
0 quarters
IMGN icon
1080
DELISTED
Immunogen Inc
IMGN
$71K ﹤0.01%
+34,769
New +$69.8K
2016 Q4
0 quarters
SGYP
1081
PUT
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$61K ﹤0.01%
10,000
-2,500
-20% -$13.1K
2016 Q2
2 quarters
ACHN
1082
DELISTED
Achillion Pharmaceuticals
ACHN
$57K ﹤0.01%
+13,754
New +$73.1K
2016 Q4
0 quarters
ARAY icon
1083
Accuray
ARAY
$22.7M
$56K ﹤0.01%
+12,104
New +$62.8K
2016 Q4
0 quarters
PACB icon
1084
Pacific Biosciences
PACB
$637M
$56K ﹤0.01%
+14,758
New +$107K
2016 Q4
0 quarters
SAN icon
1085
CALL
Banco Santander
SAN
$196B
$56K ﹤0.01%
11,374
+104
+0.9% +$473
2016 Q2
2 quarters
TGTX icon
1086
TG Therapeutics
TGTX
$8.32B
$56K ﹤0.01%
+11,975
New +$70.2K
2016 Q4
0 quarters
ISEE
1087
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$56K ﹤0.01%
+11,531
New +$342K
2016 Q4
0 quarters
IMMU
1088
CALL
DELISTED
Immunomedics Inc
IMMU
$56K ﹤0.01%
+15,300
New +$45.3K
2016 Q4
0 quarters
PLUG icon
1089
Plug Power
PLUG
$2.18B
$53K ﹤0.01%
+44,341
New +$65.1K
2016 Q4
0 quarters
IAG icon
1090
CALL
IAMGOLD
IAG
$10.4B
$43K ﹤0.01%
+11,100
New +$41.5K
2016 Q4
0 quarters
NGD
1091
DELISTED
New Gold Inc
NGD
$40K ﹤0.01%
11,500
– –
2016 Q3
1 quarter
PWE
1092
DELISTED
Penn West Energy Petroleum Ltd
PWE
$39K ﹤0.01%
21,776
+6,000
+38% +$10.3K
2016 Q1
3 quarters
GNW icon
1093
PUT
Genworth Financial
GNW
$3.36B
$38K ﹤0.01%
+10,000
New +$44.1K
2016 Q4
0 quarters
HOV icon
1094
CALL
Hovnanian Enterprises
HOV
$620M
$38K ﹤0.01%
+552
New +$27.6K
2016 Q4
0 quarters
GFI icon
1095
PUT
Gold Fields
GFI
$32.4B
$37K ﹤0.01%
+12,400
New +$44.4K
2016 Q4
0 quarters
ORIG
1096
CALL
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$36K ﹤0.01%
+2
New +$25.1K
2016 Q4
0 quarters
AUY
1097
CALL
DELISTED
Yamana Gold, Inc.
AUY
$35K ﹤0.01%
12,500
-45,600
-78% -$149K
2015 Q4
4 quarters
CEMP
1098
DELISTED
Cempra, Inc.
CEMP
$33K ﹤0.01%
+11,653
New +$141K
2016 Q4
0 quarters
PWE
1099
PUT
DELISTED
Penn West Energy Petroleum Ltd
PWE
$32K ﹤0.01%
18,000
– –
2015 Q3
5 quarters
LGCY icon
1100
CALL
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$29K ﹤0.01%
+13,600
New +$24.5K
2016 Q4
0 quarters

Similar funds

Integral Derivatives's Q4 2016 Portfolio in Review

As of Q4 2016, Integral Derivatives held 1,375 positions worth $5.4B, up 13% from $4.78B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Integral Derivatives's Q4 2016 filing shows 399 new, 402 increased, 270 reduced and 267 closed positions. Its largest new stake was Alibaba: 210,683 shares worth $18.5M. The largest sale was Lockheed Martin, an estimated $16.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Communication Services and Energy.

  • Integral Derivatives's largest Q4 2016 buy was Alibaba: 210,683 shares worth $18.5M.
  • Integral Derivatives added most to Alphabet (Google) Class A in Q4 2016, an estimated $10.8M increase.
  • Integral Derivatives's biggest Q4 2016 reduction was Lockheed Martin, cutting an estimated $16.2M.
  • Integral Derivatives fully exited LinkedIn Corporation in Q4 2016, selling an estimated $6.14M.
  • Integral Derivatives's ten largest holdings make up 52% of its $5.4B portfolio in Q4 2016.
  • Integral Derivatives opened 399 new positions and closed 267 in Q4 2016.
  • Integral Derivatives's portfolio value rose 13% quarter-over-quarter to $5.4B.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.